Abbott Laboratories (ABT) Change in Inventory (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Change in Inventory data on file, last reported at $420.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 64.71% year-over-year to $420.0 million; the trailing twelve-month figure through Mar 2026 stood at -$30.0 million (up 69.07% YoY), and the FY2025 full-year result was -$195.0 million, down 436.21% from the prior year.
• Change in Inventory improved to $420.0 million in Q1 2026, from -$234.0 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $554.0 million in Q1 2022 to a low of -$295.0 million in Q4 2023.
• A 5-year average of $113.4 million and a median of $189.0 million in 2022 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory surged 9420.0% in 2022 and slumped 256.08% in 2023, its largest moves.
• Tracing ABT's Change in Inventory over 5 years: stood at $189.0 million in 2022, then tumbled by 256.08% to -$295.0 million in 2023, then gained by 20.34% to -$235.0 million in 2024, then grew by 0.43% to -$234.0 million in 2025, then surged by 279.49% to $420.0 million in 2026.
• Business Quant data shows ABT's Change in Inventory at $420.0 million in Q1 2026, -$234.0 million in Q4 2025, and -$213.0 million in Q3 2025.